Product Recall: Losartan 50mg & 100mg Tablets

posted Mar 21, 2019, 12:02 AM by Muhammad Fikree Ahmad   [ updated Mar 21, 2019, 12:06 AM ]
20th March 2019 (Circular NO. SP PPUM:   122/2019): 


Product Name                   :                Tozaar 50mg Tablet

Active Ingredient             :                Losartan Potassium 50mg

Dosage Form                      :                Tablet 

Manufacturer                     :                Laboratories Torrent (M) Sdn. Bhd.

Formulary Category       :                Standard Formulary

Registration No.               :                MAL10110006AZ


BATCH NO.

MANUFACTURING

DATE

EXPIRY

DATE

 

BCD8C002

10/2016

09/2019

BCD8C003

10/2016

09/2019

BCD8C004

10/2016

09/2019

BCD8D001

11/2017

10/2020

BCD8D002

11/2017

10/2020

BCD8D003

11/2017

10/2020

BCD8E001

01/2018

12/2020

BCD8E002

07/2018

06/2021


Please be informed that Laboratories Torrent (M) Sdn. Bhd., the distributor of this product, has been given notice of product recall due to the adulterated active ingredient. The use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required to do prompt checking on the batch number of the current stocks. Kindly segregate the affected stocks according to the batch number and send to Inpatient Pharmacy for exchange of stocks.




21st March 2019 (Circular NO. SP PPUM:   123/2019): 












Product Name                   :                Losagen 100mg Tablet

Active Ingredient             :                Losartan Potassium 100mg

Dosage Form                      :                Tablet 

Manufacturer                     :                Unimed Sdn. Bhd.

Formulary Category       :                Standard Formulary

Registration No.               :                MAL17075010AZ


  BATCH NO.

EXPIRY DATE

 

LOP18034A

 

12/2019

 

LOP18034D

 

12/2019

 

LOP18108

 

03/2020


Please be informed that Unimed Sdn. Bhd., the distributor of this product, has been given notice of product recall due to the adulterated active ingredient. The use of this product should be stopped immediately.

Therefore, all clinical areas keeping the stocks for this product are required to do prompt checking on the batch number of the current stocks. Kindly segregate the affected stocks according to the batch number and send to Inpatient Pharmacy for exchange of stocks.